Vaccines against intracellular infections requiring cellular immunity

Nature

Volumn 406, Issue 6797, 2000, Pages 793-798

  Seder, Robert A ^a   Hill, Adrian V S ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION PREVENTION; MALARIA; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; VACCINATION;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; INFECTION; INFECTION CONTROL; VACCINES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034680182     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35021239     Document Type: Review

References (47)

1. Ahmed, R. & Gray, D. Immunological memory and protective immunity: understanding their relation. Science 272, 54-60 (1996).
2. Dutton, R. W., Bradley, L. M. & Swain, S. L. T cell memory. Annu. Rev. Immunol. 16, 201-223 (1998).
3. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
4. Gray, D. & Matzinger, P. T cell memory is short-lived in the absence of antigen. J. Exp. Med. 174, 969-974 (1991).
5. Bachmann, M. F., Kundig, T. M., Hengartner, H. & Zinkernagel, R. M. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without 'memory T cells'? Proc. Natl Acad. Sci. USA 94, 640-645 (1997).
6. Kundig, T. M. et al. On the role of antigen in maintaining cytotoxic T-cell memory. Proc. Natl Acad. Sci. USA 93, 9716-9723 (1996).
7. Lau, L. L., Jamieson, B. D., Somasundaram, T. & Ahmed, R. Cytotoxic T-cell memory without antigen. Nature 369, 648-652 (1994).
8. Tanchot, C., Lemonnier, F. A., Perarnau, B., Breitas, A. A. & Rocha, B. Differential requirements for survival and proliferation of CD8 naïve or memory T cells. Science 276, 2057-2062 (1997).
9. Murali-Krishna, K. et al. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286, 1377-1381 (1999).
10. + cell-, interferon γ-, and nitric oxide-dependent immunity. J. Exp. Med. 183, 1739-1746 (1996).
11. + T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites. Eur. J. Immunol. 29, 3978-3986 (1999).
12. Scheller, L. F. & Azad, A. F. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc. Natl Acad. Sci. USA 92, 4066-1068 (1995).
13. Matano, T. et al. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72, 164-169 (1998).
14. + lymphocytes. Science 283, 857-860 (1999).
15. Ogg, G. S. et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103-2106 (1998).
16. Kalams, S. A. et al. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J. Virol. 73, 6721-6728 (1999).
17. Ortiz, G. M. et al. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J. Clin. Invest. 104, R13-R18 (1999).
18. Swain, S. L., Hu, H. & Huston, G. Class II-independent generation of CD4 memory T cells from effectors. Science 286, 1381-1383 (1999).
19. Garcia, S., DiSanto, J. & Stockinger, B. Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity 11, 163-171 (1999).
20. Schuback, A. et al. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J. Infect. Dis. 178, 911-914 (1998).
21. + T cells in vivo by IL-15. Immunity 8, 591-599 (1998).
22. Gurunathan, S., Prussin, C., Sacks, D. I., & Seder, R. A. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nature Med. 4, 1409-1415 (1998).
23. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Med. 4, 397-402 (1998).
24. Oehen, S., Waldner, H., Kundig, T. M., Hengartner, H. & Zinkernagel, R. M. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed hy persisting antigen. J. Exp. Med. 176, 1273-1281 (1992).
25. McHeyzer-Williams, M. G. & Davis, M. M. Antigen-specific development of primary and memory T cells in vivo. Science 268, 106-111 (1995).
26. Razvi, E. S. & Welsh, R. M. Apoptosis in viral infections. Adv. Virus Res. 45, 1-60 (1995).
27. Ochsenbein, A. F. et al. A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc. Natl Acad. Sci. USA 96, 9293-9298 (1999).
28. Opferman, J. T., Ober, B. T. & Ashton-Rickardt, P. G. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283, 1745-1740 (1999).
29. Mullbacher, A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J. Exp. Med. 179, 317-321 (1994).
30. + T-cell memory determined by clonal burst size. Nature 369, 652-654 (1994).
31. + T cells in primary and secondary influenza pneumonia. Immunity 8, 683-691 (1998).
32. + T cells. Science 286, 1353-1337 (1999).
33. Lifson, J. D. et al. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J. Virol. 71, 9508-9514 (1997).
34. Ulmer, J. B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749 (1993).
35. Seder, R. A. & Gurunathan, S. DNA vaccines - designer vaccines for the 21st century. N. Engl. J. Med. 341, 277-278 (1999).
36. Wang, R. et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476-480 (1998).
37. Le, T. P. et al. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 18, 1893-1901 (2000).
38. Calarota, S. et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1 -infected patients. Lancet 351, 1320-1325 (1998).
39. Cho, H. J. et al. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nature Biotechnol. 18, 309-514 (2000).
40. Cowdery, J. S., Chace, J. H., Yi, A. K. & Krieg, A. M. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156, 4570-4575 (1996).
41. Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J. & Krieg, A. M. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl Acad. Sci. USA 93, 2879-2883 (1996).
42. Sato, Y. et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354 (1996).
43. Krieg, A. M. et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl Acad. Sci. USA 95, 12631-12636 (1998).
44. + T cells using heterologous prime-boost immunisation strategies. Immunol. Rev. 170, 29-38 (1999).
45. Kent, S. J. et al. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72, 10180-10188 (1998).
46. Hanke, T. et al. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J. Virol. 73, 7524-7532 (1999).
47. Stoute, J. A. et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med. 336, 86-91 (1997).